In this episode, you’ll be getting a booster shot by hearing from an amazing leader who believes that leadership is a privilege. Harout will give you his recipes of success in building highly engaged and performing teams. You’ll be positively surprised to hear the first ingredient!
“Even if we are standing, the world is turning and changing.”
MEET OUR GUEST Harout Semerjian, President and CEO of GlycoMimetics, a seasoned global pharmaceutical leader with a passion and focus in Oncology. Harout was elected top 10 emerging pharma executives in 2018, a strong believer in leading with care to deliver results for the patients we serve.
Harout is a seasoned biopharmaceutical leader with more than 25 years of expertise in commercializing specialty medicines across the United States, Europe, and emerging markets. He has built a reputation for building high-performance teams, leading transformations, and delivering exceptional results. He has deep expertise in oncology, hematology and rare diseases having launched more than 20 specialty products or major indications over the years. Harout spent 17 years in Novartis where his last role was Senior Vice President and global head of Ribociclib, the CDK4/6 inhibitor. Then he moved to Ipsen to be the Chief Commercial Officer and recently for a short period was the Chief Executive Officer of Immunomedics before its sale to Gilead. Currently, Harout works as a consultant and investor within healthcare.
Harout is passionate about healthcare disparities and coaching talent to achieve their full potential. In his spare time, he spends his time traveling with his family despite having a heavy travel schedule, as it provides an opportunity for his daughters to connect and expand their horizons.
